Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03771066 · ClinicalTrials.gov registry record · NA
Bisphenol A and Muscle Insulin Sensitivity
A NA study, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03771066: Completed NA study, sponsored by California Polytechnic State University-San Luis Obispo.
NCT03771066 is a NA study that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03771066, a NA study, has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.
Primary Outcome
Three hour euglycemic hyperinsulinemic clamp technique with stable glucose isotope infusion to determine rate of glucose disposal
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL bisphenol A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03771066 record still lists
NCT03771066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03771066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03771066 about?
NCT03771066 is a clinical study titled "Bisphenol A and Muscle Insulin Sensitivity". This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.
What is the current status of trial NCT03771066?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-01-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03771066?
The interventions under investigation include: Placebo (BEHAVIORAL), bisphenol A (BEHAVIORAL).
Who is sponsoring clinical trial NCT03771066?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03771066's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI